諾輝健康發佈首份常衞清用户數據報吿:陽性且腸鏡檢出異常者83.2%為癌前病變
格隆匯4月17日丨諾輝健康(6606.HK)4月15日發佈首份常衞清用户檢測數據報吿,以超50萬常衞清到檢用户的檢測結果數據分析,呼籲高風險人羣建立腸胃早篩的健康習慣,重視腸胃鏡檢查,實現結直腸癌和胃癌的有效預防。2021年至2022年,諾輝健康共計服務超50萬常衞清用户完成檢測,用户人羣覆蓋了包含港澳台全國所有34個省級行政區。報吿顯示,檢測者中位年齡為45歲,結直腸癌患者最大年齡為88歲,最小年齡為43歲;腺瘤患者最大年齡為85歲,最小年齡為23歲。陽性率最高的3個省市為上海、廣東、北京,分別為11.2%,10.8%和9.1%。從40歲開始,每10年為界,受檢者人羣40-50歲陽性率為4.2%,50-60歲陽性率為5.8%,60-70歲陽性率為9.9%,70歲以上陽性率為10.9%。以腸鏡為標準,常衞清陽性且腸鏡檢出異常發現疾病數據分別為:腺瘤、息肉佔比為83.2%,結直腸癌佔比為2.7%,其他疾病異常佔比為14.1%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.